After major breakthroughs that have twice changed the worldwide norm of AIDS therapy within the past 15 years, British Columbia’s pioneering treatment/research centre is taking the fight against the disease to a new level. Feeding on its own convincing evidence that the more aggressively you treat HIV, the more you reduce the chance of the […]
Taking the fight against AIDS to a new level Read More »
Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) will will expand access to HIV/AIDS medications among hard-to-reach and vulnerable populations in Vancouver’s inner city and Prince George. For more information on STOP HIV/AIDS, including updates on progress, please refer to our quarterly bulletin. The second edition is now available for download in PDF
STOP HIV/AIDS Update (Fall 2010) Read More »
Seek and Treat for Optimal Prevention of HIV/AIDS (STOP HIV/AIDS) will will expand access to HIV/AIDS medications among hard-to-reach and vulnerable populations in Vancouver’s Downtown East Side and Prince George. For more information on STOP HIV/AIDS, including updates on progress, please refer to our regular bulletin. The first edition is now available for download in
STOP HIV/AIDS Update (Spring/Summer 2010) Read More »
A unique pilot program will get underway shortly in Vancouver’s Downtown Eastside and Prince George to seek and treat vulnerable populations who are either undiagnosed or untreated for HIV. Vancouver – The four-year, $48-million pilot called Seek and Treat is the first of its kind in Canada and believed to be the first internationally. It
B.C. to seek and treat most vulnerable HIV patients Read More »
(Vancouver) Dr. Julio Montaner – Director, British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and President, International AIDS Society – congratulated Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), for taking a leadership role in the evaluation of the “Seek and Treat” strategy originally
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
